Schwazze Announces Participation at Noble Capital Markets Virtual Road Show Series – October 25, 2021

DENVER, CO – Oct 8, 2021 – Schwazze, (OTCQX:SHWZ)
(“Schwazze” or the “Company”), is pleased to announce their participation in Noble Capital Markets’ Virtual Road Show Series, presented by Channelchek, scheduled for October 25, 2021 at 1:00 pm EDT.

The virtual road show will feature a corporate presentation from Schwazze CEO Justin Dye & CFO Nancy Huber, followed by a Q & A session proctored by Noble Senior Research Analyst Joe Gomes, featuring questions submitted by the audience.

The live broadcast of the virtual road show is scheduled for October 25, 2021, at 1PM EDT. Registration is free and open to all investors, at any level. Register Here.

Noble’s research, as well as news and advanced market data on Schwazze is available on Channelchek.

it will attend the Benzinga Cannabis Capital Conference at the Marriott Marquis in New York City on October 14^th – 15^th and MJBizCon 2021 at the Mandalay Bay in Las Vegas on October 20^th – 22^nd.

About
Schwazze

Schwazze (OTCQX: SHWZ) is building the premier vertically integrated cannabis company in Colorado and plans to take its operating system to other states where it can develop a differentiated leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices. Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc.

Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.

Forward-Looking
Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,”, “predicts,” or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, ({ix) the ongoing COVID-19 pandemic, (x) the timing and extent of governmental stimulus programs, and (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

For further information, please contact:

Investors
Joanne Jobin
Investor Relations
Joanne.jobin@schwazze.com
647 964 0292

Media
Julie Suntrup, Schwazze
Vice President | Marketing & Merchandising
julie.suntrup@schwazze.com
303 371 0387

	Image Credit: Kindel Media (Pexels)

Marijuana, CBD, and Hemp Vapes Can Never be Mailed to Customers

While consumer marijuana companies, both medical and recreational, may soon find it easier to do business under proposed federal laws, a U.S. Postal Service (USPS) rule approved on Wednesday may cause a permanent drag on vape sales. The USPS issued its final amendments to the “Hazardous, Restricted, and Perishable Mail” rules which are designed to comply with a federal law signed last year that regulates electronic nicotine delivery systems (ENDS).

The final rule fulfills a required condition of the Preventing Online Sales of E-Cigarettes to Children Act (POSECCA) federal regulation. The federal law passed in 2020 “requires the USPS to implement regulations to prohibit the mailing of these systems”

Definition of Electronic Delivery System (ENDS)

Source: Federal Register October 21, 2021

Although the final rule specifically prohibits mailing ENDS, and states “nicotine,” Congress uses the term to describe all vaping products. Many cannabis, and hemp products, including CBD, are in the category that lawmakers banned, according to the final rule. This rule went into effect yesterday (October 21).

Comment Period

The public comment period leading up to the rule change brought in views and opinions from 15,700 citizens. Some comment themes were answered in the final written rule so as to better define the USPS inclusions and exclusions. One noteworthy decision was related to CBD. Commenters said the final rule would conflict with shipping other hemp and hemp-derived products that test under the legal 0.3% THC limit; the USPS said it is unable to go around the POSECCA because it specifically calls on the agency to prohibit the shipping of vape products and said the ban would not clash with other laws because it’s under the federal government.

Virtual Road Show Series – Monday, October 25 @ 1pm EDT Join Schwazze CEO Justin Dye and CFO Nancy Huber for this exclusive corporate presentation, followed by a Q & A session featuring questions taken from the audience. Registration is free and open to all investors, at any level. Register Now | View All Road Shows

The agency makes clear that the final rule does not interfere with the mailing of hemp and hemp derivatives that contain no more than 0.3% THC on a dry weight basis, as long as it is not “incorporated into an ENDS product or function as a component of one.”

The final rule also “exempts business-to-business shipments from the mail ban, along with shipping to consumers within the borders of Alaska and Hawaii, and limited non-commercial shipping between private individuals,”  

The USPS final rule allows for the shipping of cigarettes for “consumer testing” by public health researchers and federal agencies.

Specific Mention of
Marijuana

Source: Federal Register October 21, 2021

Take-Away

Within last year’s electronic delivery systems federal law, final rules were determined this week related to the United States Post Office. Businesses are specifically prohibited from mailing any form of electronic vaping device to a consumer. This is a new law that is not likely to be updated or changed in the foreseeable future. Many marijuana companies are building sophisticated distributor
networks of their own. The restrictions placed on the USPS may only benefit the competitiveness of these businesses. 

Suggested Reading:

Cannabis Customers Served by the Ice Cream Truck Delivery Model

Cannabis Related Businesses (CRB) New Access to Banking Services

Marijuana Dispensaries and the Impact on Use

Evaluating Opportunity With the iPhone New Marijuana Policy

 

Sources:

https://www.federalregister.gov/documents/2021/10/21/2021-22787/treatment-of-e-cigarettes-in-the-mail

https://vaping360.com/vape-news/111617/usps-final-rule-banning-vape-mail/

 

Stay up to date. Follow us:

1-800-FLOWERS.COM, Inc. to Release Results for its Fiscal 2022 First Quarter on Thursday, October 28, 2021

 

JERICHO, N.Y.–(BUSINESS WIRE)– 1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS),a leading provider of gifts designed to help customers express, connect and celebrate, today announced that the Company will release financial results for its fiscal 2022 first quarter (ended 9/26/21) on Thursday, October 28, 2021. The press release will be issued prior to market opening and will be followed by a conference call with members of senior management at 8:00 a.m. (ET).

The conference call will be available via live webcast from the Investor Relations section of the Company’s website at 1800flowersinc.com. A recording of the call will be posted on the website within two hours of the call’s completion. A telephonic replay of the call can be accessed beginning at 2:00 p.m. (ET) on October 28 through November 4, 2021, at: (US) 1-877-344-7529; (
Canada) 855-669-9658; (International) 1-412-317-0088; enter conference ID #:10161105. If you have any questions regarding the above information, please call Patty Altadonna at (516) 237-6113 or the Investor Relations office at (516) 237-6131.

Special Note Regarding Forward-Looking Statements:
Some of the statements contained in the Company’s scheduled Thursday, October 28, 2021, press release and conference call regarding its fiscal 2022 first quarter (ended 9/26/21) results, other than statements of historical fact, may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the applicable statements. For a more detailed description of these and other risk factors, please refer to the Company’s SEC filings including its Annual Reports and Forms 10K and 10Q available at the Investor Relations section of the Company’s website at 1800flowersinc.com. The Company expressly disclaims any intent or obligation to update any of the forward-looking statements made in the scheduled conference call and any recordings thereof, or in any of its SEC filings, except as may be otherwise stated by the Company.

About 1-800-FLOWERS.COM, Inc.

1-800-FLOWERS.COM, Inc. is a leading provider of gifts designed to help customers express, connect and celebrate. The Company’s e-commerce business platform features an all-star family of brands, including: 1-800-Flowers.com®, 1-800-Baskets.com®, Cheryl’s Cookies®, Harry & David®, PersonalizationMall.com®, Shari’s Berries®, FruitBouquets.com®, Moose Munch®, The Popcorn Factory®, Wolferman’s Bakery®, Stock Yards® and Simply Chocolate®. Through the Celebrations Passport® loyalty program, which provides members with free standard shipping and no service charge across our portfolio of brands, 1-800-FLOWERS.COM, Inc. strives to deepen relationships with customers. The Company also operates BloomNet®, an international floral and gift industry service provider offering a broad-range of products and services designed to help members grow their businesses profitably; Napco?, a resource for floral gifts and seasonal décor; and DesignPac Gifts, LLC, a manufacturer of gift baskets and towers. 1-800-FLOWERS.COM, Inc. was recognized among the top 5 on the National Retail Federation’s 2021 Hot 25 Retailers list, which ranks the nation’s fastest-growing retail companies. Shares in 1-800-FLOWERS.COM, Inc. are traded on the NASDAQ Global Select Market, ticker symbol: FLWS. For more information, visit 1800flowersinc.com or follow @1800FLOWERSInc on Twitter.

FLWS-COMP
FLWS-FN

Investor:

Joseph D. Pititto

(516) 237-6131

E-mail: invest@1800flowers.com

Media:

Kathleen Waugh

(516) 237-6028

kwaugh@1800flowers.com

Source: 1-800-FLOWERS.COM, Inc.

1-800-FLOWERS.COM, Inc. to Release Results for its Fiscal 2022 First Quarter on Thursday, October 28, 2021

 

JERICHO, N.Y.–(BUSINESS WIRE)– 1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS),a leading provider of gifts designed to help customers express, connect and celebrate, today announced that the Company will release financial results for its fiscal 2022 first quarter (ended 9/26/21) on Thursday, October 28, 2021. The press release will be issued prior to market opening and will be followed by a conference call with members of senior management at 8:00 a.m. (ET).

The conference call will be available via live webcast from the Investor Relations section of the Company’s website at 1800flowersinc.com. A recording of the call will be posted on the website within two hours of the call’s completion. A telephonic replay of the call can be accessed beginning at 2:00 p.m. (ET) on October 28 through November 4, 2021, at: (US) 1-877-344-7529; (
Canada) 855-669-9658; (International) 1-412-317-0088; enter conference ID #:10161105. If you have any questions regarding the above information, please call Patty Altadonna at (516) 237-6113 or the Investor Relations office at (516) 237-6131.

Special Note Regarding Forward-Looking Statements:
Some of the statements contained in the Company’s scheduled Thursday, October 28, 2021, press release and conference call regarding its fiscal 2022 first quarter (ended 9/26/21) results, other than statements of historical fact, may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the applicable statements. For a more detailed description of these and other risk factors, please refer to the Company’s SEC filings including its Annual Reports and Forms 10K and 10Q available at the Investor Relations section of the Company’s website at 1800flowersinc.com. The Company expressly disclaims any intent or obligation to update any of the forward-looking statements made in the scheduled conference call and any recordings thereof, or in any of its SEC filings, except as may be otherwise stated by the Company.

About 1-800-FLOWERS.COM, Inc.

1-800-FLOWERS.COM, Inc. is a leading provider of gifts designed to help customers express, connect and celebrate. The Company’s e-commerce business platform features an all-star family of brands, including: 1-800-Flowers.com®, 1-800-Baskets.com®, Cheryl’s Cookies®, Harry & David®, PersonalizationMall.com®, Shari’s Berries®, FruitBouquets.com®, Moose Munch®, The Popcorn Factory®, Wolferman’s Bakery®, Stock Yards® and Simply Chocolate®. Through the Celebrations Passport® loyalty program, which provides members with free standard shipping and no service charge across our portfolio of brands, 1-800-FLOWERS.COM, Inc. strives to deepen relationships with customers. The Company also operates BloomNet®, an international floral and gift industry service provider offering a broad-range of products and services designed to help members grow their businesses profitably; Napco?, a resource for floral gifts and seasonal décor; and DesignPac Gifts, LLC, a manufacturer of gift baskets and towers. 1-800-FLOWERS.COM, Inc. was recognized among the top 5 on the National Retail Federation’s 2021 Hot 25 Retailers list, which ranks the nation’s fastest-growing retail companies. Shares in 1-800-FLOWERS.COM, Inc. are traded on the NASDAQ Global Select Market, ticker symbol: FLWS. For more information, visit 1800flowersinc.com or follow @1800FLOWERSInc on Twitter.

FLWS-COMP
FLWS-FN

Investor:

Joseph D. Pititto

(516) 237-6131

E-mail: invest@1800flowers.com

Media:

Kathleen Waugh

(516) 237-6028

kwaugh@1800flowers.com

Source: 1-800-FLOWERS.COM, Inc.

Thursday, October 14, 2021

eSports Entertainment Group, Inc. (GMBL)
A Moose Or A Golden Goose?

Esports Entertainment Group Inc is a development-stage online gambling company focused purely on esports. The company’s principal business operations include design, develop and test wagering systems.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Fiscal Q4 falls short. While revenues were in line with expectations at $8.8 million, adjusted EBITDA loss was greater than expected at $5.4 million versus our loss estimate of $3.8 million. Operating expenses were significantly higher, which more than offset the better than expected gross margins.


Lowering our fiscal 2022 adj.  EBITDA estimate. Management’s Fiscal Q1 revenue guide was lighter than what we were looking for at $16.0 million to $16.5 million versus our $19.0 million estimate. Fiscal full year 2022 revenue guide was reiterated at $100 million to $105 million. We are keeping our more conservative $95 million revenue estimate. Given elevated investment levels, we are raising our …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Thursday, October 14, 2021

eSports Entertainment Group, Inc. (GMBL)
A Moose Or A Golden Goose?

Esports Entertainment Group Inc is a development-stage online gambling company focused purely on esports. The company’s principal business operations include design, develop and test wagering systems.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Fiscal Q4 falls short. While revenues were in line with expectations at $8.8 million, adjusted EBITDA loss was greater than expected at $5.4 million versus our loss estimate of $3.8 million. Operating expenses were significantly higher, which more than offset the better than expected gross margins.


Lowering our fiscal 2022 adj.  EBITDA estimate. Management’s Fiscal Q1 revenue guide was lighter than what we were looking for at $16.0 million to $16.5 million versus our $19.0 million estimate. Fiscal full year 2022 revenue guide was reiterated at $100 million to $105 million. We are keeping our more conservative $95 million revenue estimate. Given elevated investment levels, we are raising our …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Wednesday, October 13, 2021

Item 9 Labs (INLB)
Implementing Another Leg of the Growth Strategy

Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 650,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Acquisition Growth Plan. Item 9 Labs has entered into an Asset Purchase Agreement for an existing dispensary license and storefront in Adams County, CO. The national acquisition growth plan is another leg in the Company’s strategy for its Unity Rd. franchise operations, complementing the traditional franchise operation as well as the “Local Alliance” program whereby existing cannabis dispensary owners and dispensary license holders can partner with Unity Rd.


Details.  While Item 9 Labs did not provide cost or a specific location, it is anticipated the location will open within the next 4-6 months once receiving approval from the Colorado Marijuana Enforcement Division. We expect Item 9 Labs will initially operate the location as a Company-owned dispensary while seeking a franchise partner to ultimately purchase the location …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Wednesday, October 13, 2021

Stem Holdings (STMH)(STEM:CA)
Budee on the Apple App Store

Stem Holdings Inc is engaged in the purchasing, improving, and leasing of properties and finance assets which are operated by third parties and are used for the cultivation and retail sale of marijuana. Its properties includes 42nd Street, and Mulino Farm which are used for agriculture. The company generates its revenue in the form of rental income from tenants.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Apple App and Budee. Driven by Stem’s Budee e-commerce cannabis delivery platform and service has launched Budee Cannabis Delivery app, which is available for download in the Apple App store. Customers of the Budee app can now seamlessly and confidentially purchase cannabis products through their mobile device in the California and Oregon markets served by Budee, with additional markets expected by year-end.


Importance of Apple App Store.  With 113 million iPhone users in the U.S., the potential of being on the Apple App store is enormous. Already, the Apple App store is estimated to drive more than $500 billion of commerce through the more than two million available apps. Notably, being featured on the Apple App increases downloads by a median 30% for non game apps in the U.S …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

	Image Credit: "thöR (Flickr)

Reconciling Marijuana Revenue with Marijuana Company Losses

 

What if the world’s largest cannabis producer by sales is also among the marijuana businesses with the largest losses? Should it concern investors in this newly sprouted sector that the company they are waiting on to grow is growing sales, but net profit is always red? Many investors are now scratching their heads and checking their patience with the largest company in this sector.

Tilray, the largest cannabis company by sales, reported revenue rose to $168 million for the quarter ended August 31, 2021. This is over $50 million higher than the year-earlier period. At the same time, the company reported its quarterly net loss widened to $34.6 million, approximately $13 million more compared to a year ago.

 

Income Statement Highs and Lows

If you look at a company’s Income Statement, the top line is Net Revenue, it’s sometimes labeled “Sales” or “Net Sales”  As the entry title suggests this is all incoming money from goods sold, and it’s before all costs. How much of this is left after expenses determine “Net Profit” which is reported on the below example using Tilray’s Income Statement as Net Loss.

Tilray income Statement (as reported October 7, 2021)

 

Below the net revenue number is Cost of Goods Sold; these upfront raw material costs are immediately subtracted from revenue. Expenses include running the business, selling expenses, depreciation costs (amortization), marketing costs, product development, and in this case also include a high Transaction cost. After deducting all expenses, just before the double line, the statement provides the company’s “Net profit”, or in the above case Net Loss. For Tilray,  this number is a negative $36,604,000.

 

What’s More Important,
Revenue or Profit?

The first step toward profit is revenue, so revenue is very important — if a company isn’t growing revenue while the market for its product is growing, they are falling behind in market share. In rapidly growing markets, it is not uncommon for there to be more investment in building the business infrastructure, which could include expensive transactions to buy assets in other markets or verticals.

As a longer-term investor, you want management to have a vision that takes advantage of expected realities. A recent example was this past Monday when Tesla reported. The market saw another industry that was non-existent before 2008 have its largest producer turn a profit. Tesla, since it was just a seed in Elon Musk’s mind, had not turned a profit selling cars until last quarter. In many ways, the EV industry is like the cannabis industry. The potential for the future looks extremely promising, but only for those that grow big enough, fast enough to survive the competition.

The lifecycle stage of an industry is a key consideration on whether investors should be concerned with negative bottom lines. It’s expected that fundamentals in terms of more open markets and easier transactions that the cannabis industry will experience growth well beyond its current pace. With this, companies in the sector are expected to have big improvements in revenue every year but operate at a loss. They are investing aggressively to lay the groundwork for the future.

As an investor, your main question is whether you have confidence in the industry, and do you have confidence in the way the company is investing in their future for the stockholders.

Understanding and agreeing with management’s vision for the company and whether or not they are delivering on that vision provides the best answer as to whether an investor should be concerned that a company hasn’t reported a positive net profit.

 

Source: Press release dated October 7, 2021
-Tilray CEO explains building momentum growing market base.

 

If investors understand the company’s strategy and vision and believe that it will eventually reach an inflection point to become sustainable, and increasingly profitable, then the stock will attract more attention and could outperform even if earnings are negative.

Take-Away

Losses for young companies in fledgling growth industries are common. Investors should have different expectations at the early part of any industry’s lifecycle. Negative earnings on their own can be deceiving. Realistic future potential is why most investors get involved. You want forward-looking, visionary management. Investors in companies at this stage often rely more on cash flow statements for corporations investing in themselves that show strong revenue growth. Weak cash flow may create difficulties for management, whereas one might be able to discern a positive economic reality if there is solid cash flow.

Investors not in tune with the fundamentals presented in a company’s quarterly report may look to see if there are well-qualified equity analysts covering the company they’re interested in. Channelchek is a no-cost resource for research and analysis from top-ranked equity analysts covering growth industries.

Future Research Analysts

Each year Noble Capital Markets, Channelchek, and generous sponsors hold the Channelchek College Equity Research Challenge.

We invite students to compete for high cash prizes awarded to the student and the student’s college – plus an offer for an internship at the largest company-sponsored research provider in the U.S.

Who can compete?

You don’t have to be a finance, accounting, or major in a related field to understand that up to $7500 for you, and an additional $5,000 to your school can be quite helpful.  If you are fully matriculated and interested, you likely qualify.

We invite you to learn more. 

 

Suggested Content:

Schwazze – C-Suite Interview with CEO, Justin Dye (video)

Driven by Stem – Virtual Road Show Replay (video)

 

Sources:

https://www.businesswire.com/news/home/20211007005345/en/Tilray-Inc.-Reports-First-Quarter-Fiscal-Year-2022-Financial-Results

https://www.investingdaily.com/analyst/scott-chan/#archives

https://en.wikipedia.org/wiki/Tilray

https://www.newcannabisventures.com/cannabis-company-revenue-ranking/

 

Stay up to date. Follow us:

Item 9 Labs Corp. to Acquire Colorado Dispensary, Kickstarts National Acquisition Growth Plan

Franchisor of Cannabis Dispensary Franchise, Unity Rd., to Aggressively Expand by Converting Cannabis Retail Stores into Unity Rd. Shops; Company Seeks to Keep Dispensary Ownership Local by Providing Turnkey Investment Opportunities for New and Existing Unity Rd. Franchise Partners

PHOENIX, Oct. 7, 2021 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB) (the “Company”)—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—today announced it has signed an Asset Purchase Agreement (“APA”) for an existing dispensary license and storefront in Adams County, CO.

This will be the first corporate-owned shop under its cannabis dispensary franchise brand, Unity Rd., and is anticipated to open within the next 4-6 months. Currently, the Company is awaiting regulatory approval by Colorado’s Marijuana Enforcement Division (“MED”).

This APA is part of an overarching acquisition strategy that is intended to accelerate national expansion by creating turnkey investment opportunities for Unity Rd. franchise partners. The Company plans to convert acquired dispensaries into Unity Rd. shops, operate them internally and sell them to an existing or future franchise partner. This offers an expedited solution for entrepreneurs seeking immediate entry into cannabis. The Company’s dispensary acquisition program spans the entire state of Colorado, initially seeking opportunities in Denver, front range and compelling mountain towns.

“Our eyes are set on Colorado and building up the Unity Rd. brand to become one of the main players in the market,” said the Company’s Chief Strategy Officer, Jeffrey Rassas. “We’re in multiple ongoing negotiations with other Colorado dispensaries to become Unity Rd. shops. Here’s to the first of many.”

Item 9 Labs Corp. is also targeting the Arizona, Montana and Oklahoma markets as part of these development efforts. Through its Unity Rd. dispensary franchise, the Company is focused on building a national community of local dispensary owners who open their doors each day compliantly and with confidence because of the tools, products, systems and training their team provides.

“With Unity Rd., we’re keeping dispensary ownership local and thriving with the backing of a franchise system, Rassas added. “This growth plan ultimately keeps dispensary ownership in the hands of the local entrepreneur. They hire local and keep the wealth cannabis offers within their community.”

More Information on Item 9 Labs Corp. and Unity Rd.:
Visit https://investors.item9labscorp.com/

Cannabis Operators Interested in Selling Their Dispensary License:
Contact Mark Busch at acquisitions@item9labs.com

Colorado Cannabis Market Continues to Shatter Sales Records

Initially, the Company plans to operate the Adams County shop and utilize it for tours with prospective franchise partners, franchise partner and team member training and more. The shop is primed for immediate success as Colorado’s cannabis sales recently hit the highest point the state has ever seen, bringing in in 2020 – $714.9 million were from the Denver market alone. 2021 is poised to be an even more lucrative year for the Colorado cannabis market, which has already clocked in $1.1 billion in sales through June.

“While Colorado was the first state to legalize recreational cannabis seven years ago, the state is still ripe with opportunity,” explained Unity Rd.’s Chief Franchise Officer, Mike Weinberger. “In the industry, we refer to states like Colorado as mature cannabis markets, and there are plenty of perks to operating a dispensary in one. For instance, several members of our team have owned or led cannabis companies within the state – we know what it takes, are familiar with state regulations and have a deep understanding of the consumer. We’re confident that our team can create some incredible investment opportunities for prospective operators, which is all part of our mission to keep dispensary ownership in the hands of the local business owner.”

Unity Rd. offers the safest route for cannabis entrepreneurs interested in staking their claim in an industry that’s bursting with potential. The dispensary franchisor’s time-tested Standard Operating Procedures (“SOPs”) and veteran team, with a combined 120+ years of cannabis experience, guide franchise partners through every operational function of the business, whether it be securing a license or assisting with cash flow, product selection or changing regulations.

The cannabis franchise is actively seeking qualified franchise partners throughout Colorado and the United States who would benefit from the systems, processes and ongoing support the franchise offers. As it stands, Unity Rd. currently has multiple agreements signed with more than 15 entrepreneurial groups who are in various stages of development nationwide.

More Information About the Unity Rd. Franchise Opportunity:
Contact franchise@unityrd.com, Call 720-923-5262 or Visit unityrd.com

About Item 9 Labs Corp.
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 650,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com.

About Unity Rd.
Unity Rd. is bridging the two previously disconnected worlds of cannabis and franchising. The industry trailblazer is the first to bring the cannabis dispensary franchise model to the United States—with duality of prowess in both industries to back it up. Built up from a collective 200 years in the legal cannabis industry and franchising, the company helps eager operators enter the complex industry with ease. The marijuana franchise pioneer offers its partners the knowledge, resources, and ongoing support needed to compliantly and successfully operate a dispensary. Launched in 2018, Unity Rd. has signed multiple agreements with more than 15 entrepreneurial groups across the country. Recently, it was named one of the top cannabis retail leaders in the nation by MJBizDaily magazine and one of the “Best Cannabis Companies to Work For” in both the dispensary and cultivation categories in Cannabis Business Times’ elite 2020 list. The company is also the first cannabis business to earn a Franchise Times Dealmakers award. For more information, visit unityrd.com.

Forward-Looking Statement
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, proposed transactions that are not legally binding obligations of the company and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Media Contact:
Item 9 Labs
Jayne Levy, VP of Communications
Email: Jayne@item9labs.com

Investor Contact:
Item 9 Labs
800-403-1140
Email: investors@item9labs.com

SOURCE Item 9 Labs Corp.

Item 9 Labs Corp. to Acquire Colorado Dispensary, Kickstarts National Acquisition Growth Plan

Franchisor of Cannabis Dispensary Franchise, Unity Rd., to Aggressively Expand by Converting Cannabis Retail Stores into Unity Rd. Shops; Company Seeks to Keep Dispensary Ownership Local by Providing Turnkey Investment Opportunities for New and Existing Unity Rd. Franchise Partners

PHOENIX, Oct. 7, 2021 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB) (the “Company”)—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—today announced it has signed an Asset Purchase Agreement (“APA”) for an existing dispensary license and storefront in Adams County, CO.

This will be the first corporate-owned shop under its cannabis dispensary franchise brand, Unity Rd., and is anticipated to open within the next 4-6 months. Currently, the Company is awaiting regulatory approval by Colorado’s Marijuana Enforcement Division (“MED”).

This APA is part of an overarching acquisition strategy that is intended to accelerate national expansion by creating turnkey investment opportunities for Unity Rd. franchise partners. The Company plans to convert acquired dispensaries into Unity Rd. shops, operate them internally and sell them to an existing or future franchise partner. This offers an expedited solution for entrepreneurs seeking immediate entry into cannabis. The Company’s dispensary acquisition program spans the entire state of Colorado, initially seeking opportunities in Denver, front range and compelling mountain towns.

“Our eyes are set on Colorado and building up the Unity Rd. brand to become one of the main players in the market,” said the Company’s Chief Strategy Officer, Jeffrey Rassas. “We’re in multiple ongoing negotiations with other Colorado dispensaries to become Unity Rd. shops. Here’s to the first of many.”

Item 9 Labs Corp. is also targeting the Arizona, Montana and Oklahoma markets as part of these development efforts. Through its Unity Rd. dispensary franchise, the Company is focused on building a national community of local dispensary owners who open their doors each day compliantly and with confidence because of the tools, products, systems and training their team provides.

“With Unity Rd., we’re keeping dispensary ownership local and thriving with the backing of a franchise system, Rassas added. “This growth plan ultimately keeps dispensary ownership in the hands of the local entrepreneur. They hire local and keep the wealth cannabis offers within their community.”

More Information on Item 9 Labs Corp. and Unity Rd.:
Visit https://investors.item9labscorp.com/

Cannabis Operators Interested in Selling Their Dispensary License:
Contact Mark Busch at acquisitions@item9labs.com

Colorado Cannabis Market Continues to Shatter Sales Records

Initially, the Company plans to operate the Adams County shop and utilize it for tours with prospective franchise partners, franchise partner and team member training and more. The shop is primed for immediate success as Colorado’s cannabis sales recently hit the highest point the state has ever seen, bringing in in 2020 – $714.9 million were from the Denver market alone. 2021 is poised to be an even more lucrative year for the Colorado cannabis market, which has already clocked in $1.1 billion in sales through June.

“While Colorado was the first state to legalize recreational cannabis seven years ago, the state is still ripe with opportunity,” explained Unity Rd.’s Chief Franchise Officer, Mike Weinberger. “In the industry, we refer to states like Colorado as mature cannabis markets, and there are plenty of perks to operating a dispensary in one. For instance, several members of our team have owned or led cannabis companies within the state – we know what it takes, are familiar with state regulations and have a deep understanding of the consumer. We’re confident that our team can create some incredible investment opportunities for prospective operators, which is all part of our mission to keep dispensary ownership in the hands of the local business owner.”

Unity Rd. offers the safest route for cannabis entrepreneurs interested in staking their claim in an industry that’s bursting with potential. The dispensary franchisor’s time-tested Standard Operating Procedures (“SOPs”) and veteran team, with a combined 120+ years of cannabis experience, guide franchise partners through every operational function of the business, whether it be securing a license or assisting with cash flow, product selection or changing regulations.

The cannabis franchise is actively seeking qualified franchise partners throughout Colorado and the United States who would benefit from the systems, processes and ongoing support the franchise offers. As it stands, Unity Rd. currently has multiple agreements signed with more than 15 entrepreneurial groups who are in various stages of development nationwide.

More Information About the Unity Rd. Franchise Opportunity:
Contact franchise@unityrd.com, Call 720-923-5262 or Visit unityrd.com

About Item 9 Labs Corp.
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 650,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com.

About Unity Rd.
Unity Rd. is bridging the two previously disconnected worlds of cannabis and franchising. The industry trailblazer is the first to bring the cannabis dispensary franchise model to the United States—with duality of prowess in both industries to back it up. Built up from a collective 200 years in the legal cannabis industry and franchising, the company helps eager operators enter the complex industry with ease. The marijuana franchise pioneer offers its partners the knowledge, resources, and ongoing support needed to compliantly and successfully operate a dispensary. Launched in 2018, Unity Rd. has signed multiple agreements with more than 15 entrepreneurial groups across the country. Recently, it was named one of the top cannabis retail leaders in the nation by MJBizDaily magazine and one of the “Best Cannabis Companies to Work For” in both the dispensary and cultivation categories in Cannabis Business Times’ elite 2020 list. The company is also the first cannabis business to earn a Franchise Times Dealmakers award. For more information, visit unityrd.com.

Forward-Looking Statement
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, proposed transactions that are not legally binding obligations of the company and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Media Contact:
Item 9 Labs
Jayne Levy, VP of Communications
Email: Jayne@item9labs.com

Investor Contact:
Item 9 Labs
800-403-1140
Email: investors@item9labs.com

SOURCE Item 9 Labs Corp.

ACCO Brands Corporation Announces Third Quarter 2021 Earnings Webcast

 

LAKE ZURICH, Ill.–(BUSINESS WIRE)– ACCO Brands Corporation (NYSE: ACCO) today announced that it will release its third quarter 2021 earnings after the market close on October 26, 2021. The Company will host a conference call and webcast to discuss the results on October 27 at 8:30 a.m. EDT. The webcast can be accessed through the Investor Relations section of www.accobrands.com and will be available for replay.

About ACCO Brands Corporation

ACCO Brands Corporation (NYSE: ACCO) is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include Artline^®, AT-A-GLANCE^®, Barrilito^®, Derwent^®, Esselte^®, Five Star^®, Foroni^®, GBC^®, Hilroy^®, Kensington^®, Leitz^®, Mead^®, PowerA^®, Quartet^®, Rapid^®, Rexel^®, Swingline^®, Tilibra^®, Wilson Jones^® and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

Christine Hanneman
Investor Relations
(847) 796-4320

Julie McEwan
Media Relations
(937) 974-8162

Source: ACCO Brands Corporation

ACCO Brands Corporation Announces Third Quarter 2021 Earnings Webcast

 

LAKE ZURICH, Ill.–(BUSINESS WIRE)– ACCO Brands Corporation (NYSE: ACCO) today announced that it will release its third quarter 2021 earnings after the market close on October 26, 2021. The Company will host a conference call and webcast to discuss the results on October 27 at 8:30 a.m. EDT. The webcast can be accessed through the Investor Relations section of www.accobrands.com and will be available for replay.

About ACCO Brands Corporation

ACCO Brands Corporation (NYSE: ACCO) is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include Artline^®, AT-A-GLANCE^®, Barrilito^®, Derwent^®, Esselte^®, Five Star^®, Foroni^®, GBC^®, Hilroy^®, Kensington^®, Leitz^®, Mead^®, PowerA^®, Quartet^®, Rapid^®, Rexel^®, Swingline^®, Tilibra^®, Wilson Jones^® and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

Christine Hanneman
Investor Relations
(847) 796-4320

Julie McEwan
Media Relations
(937) 974-8162

Source: ACCO Brands Corporation